ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 75 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99 | -1.0% | 141,142 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $100 | -100.0% | 141,142 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $215,000 | +53.6% | 141,142 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $140,000 | -31.0% | 141,142 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $203,000 | -50.6% | 141,142 | +79.3% | 0.01% | -28.6% |
| Q4 2021 | $411,000 | +118.6% | 78,734 | +144.1% | 0.01% | +133.3% |
| Q3 2021 | $188,000 | -48.5% | 32,255 | -28.8% | 0.00% | -57.1% |
| Q2 2021 | $365,000 | +21.7% | 45,321 | +25.9% | 0.01% | +16.7% |
| Q1 2021 | $300,000 | -66.1% | 36,010 | -69.2% | 0.01% | -76.0% |
| Q4 2020 | $885,000 | +22.4% | 116,813 | +72.3% | 0.02% | -19.4% |
| Q3 2020 | $723,000 | +151.0% | 67,814 | +256.5% | 0.03% | +121.4% |
| Q2 2020 | $288,000 | -12.5% | 19,022 | +24.2% | 0.01% | +55.6% |
| Q4 2015 | $329,000 | – | 15,318 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
| Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
| Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
| Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
| TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
| Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
| ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
| THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |